REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

Petra Seibold*, Adam Webb, Miguel E. Aguado-Barrera, David Azria, Celine Bourgier, Muriel Brengues, Erik Briers, Renee Bultijnck, Patricia Calvo-Crespo, Ana Carballo, Ananya Choudhury, Alessandro Cicchetti, Johannes Classen, Elena Delmastro, Alison M. Dunning, Rebecca M. Elliott, Laura Fachal, Marie-Pierre Farcy-Jacquet, Pietro Gabriele, Elisabetta GaribaldiAntonio Gomez-Caamano, Sara Gutierrez-Enriquez, Daniel S. Higginson, Kerstie Johnson, Ramon Lobato-Busto, Meritxell Molla, Anusha Mueller, Debbie Payne, Paula Peleteiro, Giselle Post, Tiziana Rancati, Tim Rattay, Victoria Reyes, Barry S. Rosenstein, Dirk De Ruysscher, Maria Carmen De Santis, Joerg Schaefer, Thomas Schnabel, Elena Sperk, R. Paul Symonds, Hilary Stobart, Begona Taboada-Valladares, Christopher J. Talbot, Riccardo Valdagni, Ana Vega, Liv Veldeman, Tim Ward, Christian Weissenberger, Ben Vanneste, Ahmed Osman, REQUITE Consortium

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)59-67
Number of pages9
JournalRadiotherapy and Oncology
Volume138
DOIs
Publication statusPublished - Sep 2019

Keywords

  • Late radiotherapy side effects
  • Biomarkers
  • Prediction models
  • Breast cancer
  • Prostate cancer
  • Lung cancer
  • QUALITY-OF-LIFE
  • GENOME-WIDE ASSOCIATION
  • DATA METAANALYSIS SHOWS
  • REPORTED OUTCOMES
  • RADIATION-THERAPY
  • EUROPEAN-ORGANIZATION
  • NO ASSOCIATION
  • LATE TOXICITY
  • RISK
  • POLYMORPHISMS

Cite this

Seibold, P., Webb, A., Aguado-Barrera, M. E., Azria, D., Bourgier, C., Brengues, M., Briers, E., Bultijnck, R., Calvo-Crespo, P., Carballo, A., Choudhury, A., Cicchetti, A., Classen, J., Delmastro, E., Dunning, A. M., Elliott, R. M., Fachal, L., Farcy-Jacquet, M-P., Gabriele, P., ... REQUITE Consortium (2019). REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer. Radiotherapy and Oncology, 138, 59-67. https://doi.org/10.1016/j.radonc.2019.04.034